CATEGORIES

© Copyright 2004; Hanoitimes - Economic and Urban Newspaper;

The tribune of Hanoi People’s Committee

Publication Permit: 29/GP-CBC

Editor - in - Chief: Nguyen Thanh Loi

Managing Editor: Ta Thu Giang

Email : thugiang@hanoitimes.vn

Head Office: 21 Huynh Thuc Khang Street, Dong Da District, Hanoi

Branch Office: 221 Tran Phu Street, Ha Dong District, Hanoi

WORDS ON THE STREET 70th anniversary of Hanoi's Liberation Day Vietnam - Asia 2023 Smart City Summit Hanoi celebrates 15 years of administrative boundary adjustment 12th Vietnam-France decentrialized cooperation conference 31st Sea Games - Vietnam 2021 Covid-19 Pandemic
Home / Investment / News
Japan's Taisho Group offers to buy extra 7.06% stake in DHG Pharmaceutical
Ngoc Thuy 12:35, 2018/07/06
The deal is expected to cost the Japanese pharmaceutical company VND1.1 trillion (US$47.68 million).
Japan-based Taisho Group has announced its intention to purchase another 7.06% stake of DHG Pharmaceutical JSC (DHG) in a public offer at a price of VND120,000 (US$5.20) apiece, 20% higher than the market price of VND99,900 (US$4.34) at the close on July 4, DHG said in a filing to the Ho Chi Minh City Stock Exchange (HOSE). 
 
Illustration photo.
Illustration photo.
At such price, Taisho Group is expected to spend nearly VND1.1 trillion (US$47.68 million) in exchange for 9.2 million shares of Hau Giang Pharmaceutical. 

Once the deal is completed, Taisho Group will increase its holding in the Vietnamese firm to 32% or over 41.83 million shares. The proposed time to realize this public offer is within 30 to 60 days after receiving the written approval from the State Securities Commission of Vietnam (SSC) on the public offer. 

The Japanese group in early June spent VND85.5 billion (US$3.71 million) for 650,000 shares of DHG, raising its holding in the Vietnamese medicine producer to 24.94%. 

Over the past month, DHG shares have lost 13% in value. However, since its listing, the company's share value increased a whooping of 459% to VND99,900 (US$4.34) per share at the close on July 4. 

The shares then increased by 5.31% to VND105,200 (US$4.57) apiece at the close of July 5. 

On July 4, DHG Pharmaceutical's foreign ownership limit was removed, as a result, the company adjusted its strategic targets for period 2018 - 2020 to a minimum increase of revenue at 13% and pre-tax profit of at least 7%. 
Comments
Other news
12:17, 2025/02/25
Vietnam eyes top 3 in investment environment in ASEAN next 2 years: Party Chief
A key objective is to trim off at least 30% of administrative procedures and cut both business costs and unofficial fees.
18:03, 2025/02/22
Vietnam attracts South Korean tech investment at SEMICON Korea 2025
The event provided a platform for Vietnam to showcase its semiconductor potential and reaffirm its commitment to developing high-tech industries and strengthening international cooperation.
16:46, 2025/02/20
Swedish group plans US$1 billion investment in Binh Dinh recycling plant
By creating a large number of jobs and promoting a green economy, the initiative is important in establishing Vietnam as a global hub for the circular textile sector.
10:52, 2025/02/13
Samsung plans to invest in AI, semiconductors in Vietnam
Vietnam will continue improving its investment environment and driving strategic breakthroughs in order to usher in a new era of economic development.
17:20, 2025/02/07
Vietnam's data center construction costs among the lowest in Asia Pacific
The country has a lot of potential to become one of the most important data markets in the region.
21:05, 2025/02/03
Bright prospects for FDI inflows into Vietnam in 2025
Market size, growth potential, low labor costs, and stable political and social conditions continue to be Vietnam’s selling points in attracting foreign investors.